Although the precise mechanisms underlying the upregulation of prothrombin and thrombin in AD are not completely understood, a growing body of evidence suggests their potential role in the pathogenesis of this neurodegenerative disease [48,49,50,51,118,119]. This evidence concerns the gene F2 and Alzheimer disease.